Organogenesis Holdings (ORGO) Other financing activities (2018 - 2025)

Organogenesis Holdings' Other financing activities history runs 7 years deep, the most recent figure standing at $2000.0 for Q4 2025.

• On a quarterly basis, Other financing activities fell 99.81% year-over-year to $2000.0 in Q4 2025; TTM through Dec 2025 was $157000.0, a 87.41% decrease from a year earlier, with the FY2025 full-year figure at $157000.0, down 87.41% from the prior year.
• Other financing activities eased to $2000.0 in Q4 2025 per ORGO's latest filing, from $130000.0 in the prior quarter.
• Across five years, Other financing activities topped out at $1.8 million in Q2 2022 and bottomed at $2000.0 in Q4 2025.
• The 4-year median for Other financing activities is $180000.0 (2024), against an average of $436307.7.
• Biggest YoY gain for Other financing activities was 3150.0% in 2025; the steepest drop was 99.81% in 2025.
• Year by year, Other financing activities stood at $83000.0 in 2021, then sank by 66.27% to $28000.0 in 2022, then soared by 3696.43% to $1.1 million in 2024, then sank by 99.81% to $2000.0 in 2025.
• Per Business Quant, the three latest ORGO Other financing activities figures stand at $2000.0 (Q4 2025), $130000.0 (Q3 2025), and $25000.0 (Q1 2025).